GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » PS Ratio

BIOQ (Bioqual) PS Ratio : 1.68 (As of Dec. 13, 2024)


View and export this data going back to . Start your Free Trial

What is Bioqual PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Bioqual's share price is $67.50. Bioqual's Revenue per Share for the trailing twelve months (TTM) ended in May. 2018 was $40.19. Hence, Bioqual's PS Ratio for today is 1.68.

The historical rank and industry rank for Bioqual's PS Ratio or its related term are showing as below:

BIOQ's PS Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.95
* Ranked among companies with meaningful PS Ratio only.

Bioqual's Revenue per Sharefor the six months ended in May. 2018 was $40.19. Its Revenue per Share for the trailing twelve months (TTM) ended in May. 2018 was $40.19.

Back to Basics: PS Ratio


Bioqual PS Ratio Historical Data

The historical data trend for Bioqual's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual PS Ratio Chart

Bioqual Annual Data
Trend May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 0.32 0.32 0.89 0.83

Bioqual Semi-Annual Data
May96 May97 May98 May99 May00 May01 May03 May04 May05 May06 May07 May10 May11 May17 May18
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.32 0.32 0.89 0.83

Competitive Comparison of Bioqual's PS Ratio

For the Diagnostics & Research subindustry, Bioqual's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioqual's PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioqual's PS Ratio distribution charts can be found below:

* The bar in red indicates where Bioqual's PS Ratio falls into.



Bioqual PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Bioqual's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=67.50/40.185
=1.68

Bioqual's Share Price of today is $67.50.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Bioqual's Revenue per Share for the trailing twelve months (TTM) ended in May. 2018 was $40.19.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Bioqual  (OTCPK:BIOQ) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Bioqual PS Ratio Related Terms

Thank you for viewing the detailed overview of Bioqual's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioqual Business Description

Traded in Other Exchanges
N/A
Address
9620 Medical Center Drive, Suite 310, Rockville, MD, USA, 20850
Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.
Executives
Williams Frank E Jr other: Communication, See Remarks 2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual Headlines